Bloomage BioTechnology Corporation Limited (SHA:688363)
China
· Delayed Price · Currency is CNY 50.16
+0.32 (0.64%)
Feb 21, 2025, 3:00 PM CST
SHA:688363 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 23,995 | 32,239 | 65,081 | 74,544 | 70,286 | 40,032 | Upgrade
|
| Market Cap Growth | -19.24% | -50.46% | -12.69% | 6.06% | 75.58% | - | Upgrade
|
| Enterprise Value | 23,790 | 31,288 | 63,593 | 73,055 | 68,406 | 39,367 | Upgrade
|
| Last Close Price | 50.16 | 66.54 | 133.59 | 152.76 | 143.85 | 81.72 | Upgrade
|
| PE Ratio | 55.06 | 54.41 | 67.03 | 95.28 | 108.83 | 68.36 | Upgrade
|
| Forward PE | 36.63 | 29.56 | 51.50 | 90.88 | 82.59 | 51.17 | Upgrade
|
| PS Ratio | 4.23 | 5.31 | 10.23 | 15.07 | 26.70 | 21.23 | Upgrade
|
| PB Ratio | 3.42 | 4.62 | 9.74 | 13.07 | 14.01 | 8.80 | Upgrade
|
| P/TBV Ratio | 5.37 | 5.20 | 11.01 | 14.43 | 15.56 | 9.78 | Upgrade
|
| P/FCF Ratio | - | - | - | 151.56 | - | - | Upgrade
|
| P/OCF Ratio | 45.67 | 46.08 | 102.46 | 58.42 | 99.68 | 109.71 | Upgrade
|
| EV/Sales Ratio | 4.15 | 5.15 | 10.00 | 14.77 | 25.98 | 20.88 | Upgrade
|
| EV/EBITDA Ratio | 32.85 | 40.55 | 56.57 | 84.27 | 92.41 | 53.97 | Upgrade
|
| EV/EBIT Ratio | 54.76 | 54.87 | 66.14 | 97.87 | 102.09 | 58.84 | Upgrade
|
| EV/FCF Ratio | -199.93 | - | - | 148.53 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.04 | 0.03 | 0.06 | 0.05 | 0.00 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.42 | 0.25 | 0.33 | 0.33 | 0.03 | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.61 | - | - | Upgrade
|
| Asset Turnover | 0.67 | 0.71 | 0.79 | 0.75 | 0.49 | 0.54 | Upgrade
|
| Inventory Turnover | 1.22 | 1.45 | 1.58 | 1.89 | 1.29 | 1.59 | Upgrade
|
| Quick Ratio | 0.99 | 1.47 | 1.61 | 2.20 | 4.59 | 9.31 | Upgrade
|
| Current Ratio | 2.36 | 2.56 | 2.45 | 2.84 | 6.63 | 10.31 | Upgrade
|
| Return on Equity (ROE) | 6.20% | 8.53% | 15.52% | 14.47% | 13.48% | 18.66% | Upgrade
|
| Return on Assets (ROA) | 3.19% | 4.16% | 7.43% | 7.06% | 7.84% | 11.87% | Upgrade
|
| Return on Capital (ROIC) | 3.74% | 5.00% | 9.19% | 8.45% | 8.73% | 13.26% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.75% | 7.87% | 13.66% | 12.23% | 12.98% | 14.53% | Upgrade
|
| Earnings Yield | 1.83% | 1.84% | 1.49% | 1.05% | 0.92% | 1.46% | Upgrade
|
| FCF Yield | -0.50% | -1.03% | -0.09% | 0.66% | -0.08% | -0.21% | Upgrade
|
| Dividend Yield | 0.76% | 0.57% | 0.46% | 0.32% | 0.29% | 0.45% | Upgrade
|
| Payout Ratio | 41.94% | 51.55% | 25.01% | 25.69% | 27.50% | - | Upgrade
|
| Buyback Yield / Dilution | 0.01% | 0.27% | -0.03% | -0.95% | -9.47% | -1.53% | Upgrade
|
| Total Shareholder Return | 0.77% | 0.84% | 0.43% | -0.62% | -9.18% | -1.08% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.